221 related articles for article (PubMed ID: 16754439)
1. Markets and public health: pushing and pulling vaccines into production.
Wynia MK
Am J Bioeth; 2006; 6(3):3-6. PubMed ID: 16754439
[No Abstract] [Full Text] [Related]
2. Preventing influenza--the case for immunizing children at school.
School Nurse News; 2008 Nov; 25(5):9. PubMed ID: 19146061
[No Abstract] [Full Text] [Related]
3. Liability for vaccine-related injuries: public health considerations and some reflections on the swine flu experience.
Baynes TE
Leg Med Annu; 1978; ():195-24. PubMed ID: 390278
[No Abstract] [Full Text] [Related]
4. [Biomedical research: private interests and public interests].
Martin J
Sante Publique; 2001 Mar; 13(1):89-93. PubMed ID: 11525046
[No Abstract] [Full Text] [Related]
5. Biomedical patents and the public's health: is there a role for eminent domain?
Kesselheim AS; Avorn J
JAMA; 2006 Jan; 295(4):434-7. PubMed ID: 16434634
[No Abstract] [Full Text] [Related]
6. Wyeth responds to criticism.
Stiles GM
Md Med; 2005; 6(4):5, 7-8; author reply 8. PubMed ID: 16454430
[No Abstract] [Full Text] [Related]
7. Judging public health research: epistemology, public health and the law.
Wynia MK
Am J Bioeth; 2005; 5(6):4-7. PubMed ID: 16282101
[No Abstract] [Full Text] [Related]
8. Indian biotechnology--rapidly evolving and industry led.
Kumar NK; Quach U; Thorsteinsdóttir H; Somsekhar H; Daar AS; Singer PA
Nat Biotechnol; 2004 Dec; 22 Suppl():DC31-6. PubMed ID: 15583682
[No Abstract] [Full Text] [Related]
9. [The medical-industrial complex: an ethical challenge].
Engelhardt K
Dtsch Med Wochenschr; 2005 Jul; 130(30):1778-80. PubMed ID: 16049885
[No Abstract] [Full Text] [Related]
10. The development of China's medical biotech industry needs to be driven by innovation.
Yu Z; Dai Y
Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752
[TBL] [Abstract][Full Text] [Related]
11. The Human Genome Project: a public good.
Hudson K
Health Matrix Clevel; 2002; 12(2):367-75. PubMed ID: 12430360
[No Abstract] [Full Text] [Related]
12. South Korean biotechnology--a rising industrial and scientific powerhouse.
Wong J; Quach U; Thorsteinsdóttir H; Singer PA; Daar AS
Nat Biotechnol; 2004 Dec; 22 Suppl():DC42-7. PubMed ID: 15583684
[No Abstract] [Full Text] [Related]
13. The emergence of Egyptian biotechnology from generics.
Abdelgafar B; Thorsteinsdóttir H; Quach U; Singer PA; Daar AS
Nat Biotechnol; 2004 Dec; 22 Suppl():DC25-30. PubMed ID: 15583680
[No Abstract] [Full Text] [Related]
14. Interaction between optometrists and industry representatives.
Optometry; 2009 Mar; 80(3):149-53. PubMed ID: 19271358
[No Abstract] [Full Text] [Related]
15. Conflict questions. Insurance execs on healthcare boards prompts worry.
Benko LB
Mod Healthc; 2005 May; 35(22):10. PubMed ID: 15940804
[No Abstract] [Full Text] [Related]
16. [Does the public sector have an independent research role in the development of drugs?].
Poulsen HE; Grønlykke TB
Ugeskr Laeger; 2003 Apr; 165(16):1674-6. PubMed ID: 12756828
[TBL] [Abstract][Full Text] [Related]
17. Global health. Public-private partnerships proliferate.
Cohen J
Science; 2006 Jan; 311(5758):167. PubMed ID: 16410497
[No Abstract] [Full Text] [Related]
18. Public-private partnerships in drug development for underdeveloped countries: an interview with Craig Wheeler, President of Chiron's Biopharmaceutical Division. Interview by Thomasine Kushner.
Wheeler C
Camb Q Healthc Ethics; 2003; 12(4):429-33. PubMed ID: 14619375
[No Abstract] [Full Text] [Related]
19. Triage in the nation's medicine cabinet: the puzzling scarcity of vaccines and other drugs.
Noah L
S C Law Rev; 2002; 54(2):371-403. PubMed ID: 15156891
[TBL] [Abstract][Full Text] [Related]
20. Leopards and ghosts in the temple.
McKneally MF
J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1339-40. PubMed ID: 22014716
[No Abstract] [Full Text] [Related]
[Next] [New Search]
